A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy

NCT00225095 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Recovery Following Partial Medial Meniscectomy

Interventions

DRUG: Mesenchymal Stem Cells
DRUG: Hyaluronan

Sponsor

Mesoblast International Sàrl

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]